These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 28097746

  • 21. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
    Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, Xu Y, Wu YF, Xia X, Wei W, Hu B.
    Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
    [Abstract] [Full Text] [Related]

  • 22. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
    Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of longitudinal and radial left ventricular functions on 2-D and 3-D echocardiography before and after intravenous immunoglobulin in acute Kawasaki disease.
    Hashimoto I, Saitou Y, Sakata N, Shibata K.
    Pediatr Int; 2017 Dec; 59(12):1229-1235. PubMed ID: 28892213
    [Abstract] [Full Text] [Related]

  • 24. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
    Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E.
    Turk J Pediatr; 2020 Dec; 62(1):1-9. PubMed ID: 32253860
    [Abstract] [Full Text] [Related]

  • 25. Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease.
    Chang LS, Lin YJ, Yan JH, Guo MM, Lo MH, Kuo HC.
    BMC Pediatr; 2020 Aug 24; 20(1):398. PubMed ID: 32838756
    [Abstract] [Full Text] [Related]

  • 26. Lack of CD4⁺CD25⁺FOXP3⁺ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease.
    Hirabayashi Y, Takahashi Y, Xu Y, Akane K, Villalobos IB, Okuno Y, Hasegawa S, Muramatsu H, Hama A, Kato T, Kojima S.
    Eur J Pediatr; 2013 Jun 24; 172(6):833-7. PubMed ID: 23340699
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
    Lancet Child Adolesc Health; 2018 Dec 24; 2(12):855-862. PubMed ID: 30337183
    [Abstract] [Full Text] [Related]

  • 28. Higher efficacy of infliximab than immunoglobulin on Kawasaki disease, a meta-analysis.
    Li X, Tang Y, Ding Y, Chen Y, Hou M, Sun L, Qian G, Qin L, Lv H.
    Eur J Pharmacol; 2021 May 15; 899():173985. PubMed ID: 33652059
    [Abstract] [Full Text] [Related]

  • 29. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
    Nandi A, Pal P, Basu S.
    Rheumatol Int; 2019 Oct 15; 39(10):1797-1801. PubMed ID: 31302740
    [Abstract] [Full Text] [Related]

  • 30. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
    Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
    Cardiovasc Ther; 2021 Oct 15; 2021():6660407. PubMed ID: 34239607
    [Abstract] [Full Text] [Related]

  • 31. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease.
    Manlhiot C, Yeung RS, Chahal N, McCrindle BW.
    Pediatr Allergy Immunol; 2010 May 15; 21(3):515-21. PubMed ID: 20546528
    [Abstract] [Full Text] [Related]

  • 32. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
    Fabi M, Andreozzi L, Corinaldesi E, Bodnar T, Lami F, Cicero C, Tchana B, Landini C, Sprocati M, Bigucci B, Balsamo C, Sogno Valin P, Di Fazzio G, Iughetti L, Valletta E, Marchetti F, Donti A, Lanari M.
    Eur J Pediatr; 2019 Mar 15; 178(3):315-322. PubMed ID: 30499051
    [Abstract] [Full Text] [Related]

  • 33. The factors affecting the disease course in Kawasaki disease.
    Arslanoglu Aydin E, Ertugrul I, Bilginer Y, Batu ED, Sonmez HE, Demir S, Arici ZS, Sag E, Alehan D, Ozen S.
    Rheumatol Int; 2019 Aug 15; 39(8):1343-1349. PubMed ID: 31139951
    [Abstract] [Full Text] [Related]

  • 34. Neutrophil percentage-to-albumin ratio is a potential marker of intravenous immunoglobulin resistance in Kawasaki disease.
    Deng L, Wang T, Duan Y, Liu B, Jiang J, Liu D, Li G.
    Sci Rep; 2024 Jul 02; 14(1):15232. PubMed ID: 38956281
    [Abstract] [Full Text] [Related]

  • 35. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD.
    Acta Paediatr; 2010 Oct 02; 99(10):1578-83. PubMed ID: 20491705
    [Abstract] [Full Text] [Related]

  • 36. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
    Liu F, Ding Y, Yin W.
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec 02; 15(12):1109-12. PubMed ID: 24342209
    [Abstract] [Full Text] [Related]

  • 37. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease.
    Tsujimoto H, Takeshita S, Nakatani K, Kawamura Y, Tokutomi T, Sekine I.
    Clin Immunol; 2002 May 02; 103(2):161-8. PubMed ID: 12027421
    [Abstract] [Full Text] [Related]

  • 38. Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease.
    Chen CJ, Huang FC, Tiao MM, Huang YH, Lin LY, Yu HR, Yang KD, Huang YC, Chen CC, Chang WC, Kuo HC.
    ScientificWorldJournal; 2012 May 02; 2012():485758. PubMed ID: 22792043
    [Abstract] [Full Text] [Related]

  • 39. Neutrophil-Lymphocyte Ratio for Predicting Coronary Artery Lesions in Children With Kawasaki Disease.
    Chidambaram AC, Ramamoorthy JG, Anantharaj A.
    Indian Pediatr; 2023 Mar 15; 60(3):207-211. PubMed ID: 36604937
    [Abstract] [Full Text] [Related]

  • 40. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK, Prasad D, Umali Pamintuan MA, Mammen-Prasad E, Petrova A.
    Pediatr Neonatol; 2014 Oct 15; 55(5):387-92. PubMed ID: 24636168
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.